CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations - Aix-Marseille Université Access content directly
Journal Articles Pharmacogenomics Year : 2012

CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations

Domains

Cancer
No file

Dates and versions

hal-01707696 , version 1 (13-02-2018)

Identifiers

Cite

Joseph Ciccolini, Lithaty M’batchi, Bertrand Pourroy, Cédric Mercier, Athanassios Iliadis, et al.. CDA deficiency as a possible culprit for life-threatening toxicities after cytarabine plus 6-mercaptopurine therapy: pharmacogenetic investigations. Pharmacogenomics, 2012, 13 (4), pp.393 - 397. ⟨10.2217/pgs.11.175⟩. ⟨hal-01707696⟩

Collections

UNIV-AMU INP
26 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More